The Ingestible Thermometers Market is estimated to be valued at USD 1.4 billion in 2025 and is projected to reach USD 2.4 billion by 2035, registering a compound annual growth rate (CAGR) of 5.4% over the forecast period.
| Metric | Value |
|---|---|
| Ingestible Thermometers Market Estimated Value in (2025 E) | USD 1.4 billion |
| Ingestible Thermometers Market Forecast Value in (2035 F) | USD 2.4 billion |
| Forecast CAGR (2025 to 2035) | 5.4% |
The Ingestible Thermometers market is experiencing significant growth driven by the increasing demand for minimally invasive and real-time internal body temperature monitoring solutions. The future outlook for this market is shaped by the rising adoption of wearable and ingestible medical devices that provide precise and continuous patient monitoring. Growing emphasis on patient safety, accurate diagnostics, and efficient clinical management is driving the uptake of ingestible thermometers across hospitals and healthcare facilities.
Advances in sensor technology, biocompatible materials, and wireless data transmission have enhanced the reliability and usability of ingestible devices, supporting broader clinical adoption. Additionally, the rising prevalence of gastrointestinal disorders and the need for continuous monitoring during critical care and diagnostic procedures are creating new growth opportunities.
Healthcare providers are increasingly investing in innovative monitoring technologies that reduce patient discomfort and improve clinical outcomes As regulatory approvals and technological advancements continue to evolve, the market is expected to expand steadily, offering scalable solutions for both acute and chronic patient monitoring scenarios in global healthcare systems.
The ingestible thermometers market is segmented by product type, application, end user type, and geographic regions. By product type, ingestible thermometers market is divided into Ingestible Pills, Rectal Pills, Oesophageal Pills, Intestinal Pills, Data Recorder, Software, Barcode Scanner, and Monitoring Systems. In terms of application, ingestible thermometers market is classified into Gastrointestinal, Surgical, Tropical Medicine, Veterinary, Space Research, Chemotherapy Treatment, Diseases Diagnosis, Sleep Disorder Analysis, Food & Nutrition, and Sports. Based on end user type, ingestible thermometers market is segmented into Hospitals, Clinics, Veterinary Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Research Institutes, and Home Care Settings. Regionally, the ingestible thermometers industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The ingestible pills segment is projected to hold 25.00% of the Ingestible Thermometers market revenue share in 2025, establishing it as a leading product type. This growth is driven by the convenience and non-invasive nature of ingestible pills, which allow internal body temperature monitoring without causing patient discomfort.
The segment has benefited from advancements in biocompatible sensor technology and wireless data transmission, enabling accurate real-time monitoring and integration with clinical management systems. Hospitals and healthcare providers prefer ingestible pills for continuous temperature tracking during diagnostic and treatment procedures, especially in patients where traditional monitoring methods are impractical.
The segment’s expansion is also supported by increasing demand for patient-centric medical devices that improve clinical decision-making while minimizing intervention Scalability, reliability, and ease of use have positioned ingestible pills as a preferred choice for medical facilities seeking innovative monitoring solutions, contributing to their dominant market share.
The gastrointestinal application segment is expected to account for 20.00% of the Ingestible Thermometers market revenue share in 2025, making it a leading application area. The growth of this segment is driven by the need for precise internal temperature monitoring during gastrointestinal diagnostics, endoscopic procedures, and treatment of related disorders.
Ingestible thermometers allow real-time data collection within the digestive tract, enhancing the accuracy of clinical assessments and treatment planning. Advancements in sensor miniaturization, wireless connectivity, and biocompatibility have improved device performance, enabling seamless integration into gastrointestinal monitoring protocols.
Additionally, increasing prevalence of gastrointestinal conditions and the focus on minimally invasive diagnostic methods have reinforced the adoption of ingestible thermometers in this segment The ability to monitor internal body temperature accurately without patient discomfort has strengthened the clinical preference for these devices, supporting consistent market growth.
The hospitals end user segment is anticipated to account for 30.00% of the Ingestible Thermometers market revenue share in 2025, establishing it as the leading end-use category. This growth is driven by the rising demand for advanced patient monitoring solutions that ensure safety and efficiency during diagnostic and therapeutic procedures.
Ingestible thermometers provide hospitals with the ability to continuously track internal body temperature in patients, supporting timely and data-driven clinical decision-making. The integration of ingestible devices with hospital information systems and remote monitoring platforms enhances operational efficiency and reduces manual intervention.
Additionally, hospitals are increasingly adopting innovative technologies that improve patient outcomes, minimize procedural risks, and enhance the overall quality of care The reliability, ease of use, and real-time data capabilities of ingestible thermometers make them a preferred choice for healthcare providers, contributing significantly to the segment’s dominant revenue share.
Ingestible Thermometers are basically ingestible sensors or pills that record body temperature and heart beat data continuously and transmit this data into an external device for graphical interpretation. In general, ingestible thermometers commercially available in the market is used orally.
Ingestible thermometers are swallowed by the individuals and the data is recoded as it passes through the intestine before being excreted by the body in later hours. In the market, ingestible thermometers find applications in athletics or sports, military, gastrointestinal treatment and animal care.
| Country | CAGR |
|---|---|
| China | 7.3% |
| India | 6.8% |
| Germany | 6.2% |
| Brazil | 5.7% |
| USA | 5.1% |
| U.K. | 4.6% |
| Japan | 4.1% |
The Ingestible Thermometers Market is expected to register a CAGR of 5.4% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 7.3%, followed by India at 6.8%. Developed markets such as Germany, France, and the U.K. continue to expand steadily, while the U.S. is likely to grow at consistent rates. Japan posts the lowest CAGR at 4.1%, yet still underscores a broadly positive trajectory for the global Ingestible Thermometers Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 6.2%. The U.S. Ingestible Thermometers Market is estimated to be valued at USD 546.9 million in 2025 and is anticipated to reach a valuation of USD 546.9 million by 2035. Sales are projected to rise at a CAGR of 0.0% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 73.7 million and USD 36.9 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 1.4 Billion |
| Product Type | Ingestible Pills, Rectal Pills, Oesophageal Pills, Intestinal Pills, Data Recorder, Software, Barcode Scanner, and Monitoring Systems |
| Application | Gastrointestinal, Surgical, Tropical Medicine, Veterinary, Space Research, Chemotherapy Treatment, Diseases Diagnosis, Sleep Disorder Analysis, Food & Nutrition, and Sports |
| End User Type | Hospitals, Clinics, Veterinary Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Research Institutes, and Home Care Settings |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | International Paper Company, Georgia-Pacific LLC, Smurfit Kappa, Mondi Group, Amcor Limited, Nichols Paper Products Company, Inc., Uflex Ltd., Moore Packaging Corporation, and Dynapac Co., Ltd. |
The global ingestible thermometers market is estimated to be valued at USD 1.4 billion in 2025.
The market size for the ingestible thermometers market is projected to reach USD 2.4 billion by 2035.
The ingestible thermometers market is expected to grow at a 5.4% CAGR between 2025 and 2035.
The key product types in ingestible thermometers market are ingestible pills, rectal pills, oesophageal pills, intestinal pills, data recorder, software, barcode scanner and monitoring systems.
In terms of application, gastrointestinal segment to command 20.0% share in the ingestible thermometers market in 2025.
Explore Similar Insights
Ingestible Thermometers Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
